Ryan Specialty (NYSE:RYAN) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Ryan Specialty (NYSE:RYAN) announced its quarterly earnings data on Thursday. The company reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.04, FiscalAI reports. The company had revenue of $795.23 million for the quarter, compared to analysts’ expectations of $781.44 million. Ryan Specialty had a net margin of 8.21% and a return on equity of 41.30%. The business’s revenue was up 15.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.39 EPS.

Here are the key takeaways from Ryan Specialty’s conference call:

• Q1 results were strong — total revenue rose 15% to $795 million, adjusted EBITDA grew 15.7% to $232 million (margin 29.2%), adjusted EPS increased 20% to $0.47, and the company repurchased $40 million of stock.
• Management cut its 2026 outlook to mid-single-digit organic growth (≈4–6%)100–150 basis points driven by significant property rate declines and intensified competition.
• The firm is accelerating its AI and digital transformation, reporting material efficiency gains — e.g., submission turnaround in some workflows fell from ~24 hours to under 2 hours, facultative reinsurance reviews from ~2 hours to minutes, and faster quote speeds across programs.
• Diversification via delegated authority and reinsurance is a growth driver — Ryan Re is approaching ~$2 billion in premium (including the Markel contribution), new alternative capital vehicles like RAC Re were launched, and underwriting management represents an expanding share of revenue.

Ryan Specialty Stock Down 11.2%

Shares of RYAN stock traded down $3.89 during trading on Friday, hitting $30.89. 5,971,982 shares of the company were exchanged, compared to its average volume of 1,920,499. The company has a debt-to-equity ratio of 2.62, a quick ratio of 0.98 and a current ratio of 0.98. The firm has a market capitalization of $8.16 billion, a price-to-earnings ratio of 73.54, a P/E/G ratio of 0.94 and a beta of 0.68. The business’s 50-day simple moving average is $36.08 and its 200 day simple moving average is $46.46. Ryan Specialty has a twelve month low of $29.91 and a twelve month high of $72.50.

Ryan Specialty Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 26th. Investors of record on Tuesday, May 12th will be issued a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Tuesday, May 12th. Ryan Specialty’s dividend payout ratio (DPR) is currently 123.81%.

Insider Activity at Ryan Specialty

In related news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the firm’s stock in a transaction that occurred on Monday, February 23rd. The stock was acquired at an average cost of $39.96 per share, for a total transaction of $1,018,980.00. Following the completion of the acquisition, the director owned 428,295 shares in the company, valued at $17,114,668.20. This trade represents a 6.33% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 52.03% of the company’s stock.

Institutional Trading of Ryan Specialty

Several institutional investors have recently made changes to their positions in RYAN. Royal Bank of Canada boosted its holdings in shares of Ryan Specialty by 10.6% during the first quarter. Royal Bank of Canada now owns 59,639 shares of the company’s stock worth $4,406,000 after purchasing an additional 5,739 shares during the period. AQR Capital Management LLC boosted its holdings in shares of Ryan Specialty by 25.1% during the first quarter. AQR Capital Management LLC now owns 4,972 shares of the company’s stock worth $367,000 after purchasing an additional 998 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of Ryan Specialty by 46.3% during the first quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company’s stock worth $27,787,000 after purchasing an additional 119,055 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Ryan Specialty by 11.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company’s stock worth $24,586,000 after purchasing an additional 33,667 shares during the period. Finally, Creative Planning boosted its holdings in shares of Ryan Specialty by 15.4% during the second quarter. Creative Planning now owns 4,586 shares of the company’s stock worth $312,000 after purchasing an additional 613 shares during the period. 84.82% of the stock is currently owned by institutional investors and hedge funds.

More Ryan Specialty News

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: Q1 results beat expectations — EPS $0.47 vs. $0.43 est.; revenue $795.2M, +15.2% YoY and above consensus. Management reported 11.8% organic revenue growth and strong profitability metrics (ROE ~46%). This provides fundamental backing for the business after the quarter. Business Wire: Q1 Results
• Positive Sentiment: Keefe, Bruyette & Woods kept an “outperform” rating while lowering its price target to $42 (still implies sizable upside vs. current levels), offering some analyst support for the stock. Benzinga: KBW PT
• Positive Sentiment: Board announced a quarterly dividend of $0.13/share (ex-div May 12; pay May 26), an annualized yield ~1.7% — modest income support for shareholders.
• Neutral Sentiment: Earnings call transcript and additional coverage are available for detailed readouts of management commentary on growth drivers and expense trends — useful for assessing forward guidance and margin drivers. Seeking Alpha: Q1 Call Transcript
• Neutral Sentiment: Multiple outlets (Zacks, Yahoo, MSN) ran summaries noting the beat and key metrics; these amplify visibility but add little new information beyond the press release and call. Zacks: Earnings Coverage
• Negative Sentiment: Piper Sandler cut its price target from $43 to $35 and moved to “neutral” — this reduces some analyst-implied upside and likely pressured sentiment. Benzinga: Piper Sandler PT Cut
• Negative Sentiment: Wells Fargo reaffirmed an “equal weight” stance but slashed its target from $42 to $31, leaving little upside relative to the current price and adding downside risk. Benzinga: Wells Fargo PT Cut

Analysts Set New Price Targets

Several research firms have recently weighed in on RYAN. UBS Group set a $35.00 target price on shares of Ryan Specialty in a research report on Friday. Mizuho set a $35.00 target price on shares of Ryan Specialty in a research report on Friday. Zacks Research downgraded shares of Ryan Specialty from a “hold” rating to a “strong sell” rating in a research report on Tuesday, February 24th. Weiss Ratings downgraded shares of Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, February 5th. Finally, Morgan Stanley dropped their target price on shares of Ryan Specialty from $55.00 to $50.00 and set an “overweight” rating on the stock in a research report on Monday, April 6th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, Ryan Specialty presently has an average rating of “Hold” and a consensus target price of $47.47.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.